baber/WOPTO huggingface dataset:
Patent EP-3190238-A2 (EP)
Inventor: BUDICH MEINRAD
IPC: E03D9/03
Filed: 2016-12-29
Abstract: Es wird ein WC-Wirkstoffhalter (1, 1', 1") mit einem Behälter (10, 40, 70) zur Aufnahme eines Wirkstoffs (W) und einem Aufhängebügel (30, 60, 90) zum Einhängen des WC-Wirkstoffhalters (1, 1', 1") am Rand einer Toilettenschüssel beschrieben, wobei der Aufhängebügel (30, 60, 90) beweglich am Behälter (10, 40, 70) angeordnet und um eine Schwenkachse (S) von einer ersten Stellung (P1) in eine zweite Stellung (P2) verschwenkbar ist. Dabei ist am Behälter (10, 40, 70) an einer zum Aufhängebügel (30, 60, 90) weisenden Oberseite (10o, 40o, 70o) ein Vorsprungselement (20, 50, 80) angeordnet, welches sich quer zu einer Längsachse (L) des Behälters (10, 40, 70) nach außen erstreckt. Die Schwenkachse (S) befindet sich im Bereich des Vorsprungselements (20, 50, 80) oberhalb, in einem Abstand von der Oberseite (10o, 40o, 70o), des Behälters (10, 40, 70).
Patent EP-3317292-A2 (EP)
Title: Formes à l'état solide de linaclotide
Inventor: EIDELMAN CHAIM
IPC: A61K38/10
Filed: 2016-07-01
Abstract: Des formes à l'état solide de Linaclotide, des procédés pour leur préparation, des compositions les comprenant et des utilisations médicales de ceux-ci sont proposés. Les formes à l'état solide de Linaclotide sont utiles dans la préparation d'autres formes à l'état solide de Linaclotide, en particulier la forme amorphe.
Patent EP-3208693-A2 (EP)
Inventor: GRANT DANNY
IPC: G06F3/0338
Filed: 2017-02-16
Abstract: A modular peripheral device assembly is disclosed. The assembly includes a handheld controller and an assembly base. The handheld controller includes a user input component, a sensor, and a first magnet. The sensor is configured to track at least one of motion and orientation of the handheld controller. The first magnet in the handheld controller is located at an attachment region of the controller. The assembly base is attachable to and detachable from the handheld controller, and comprises a first attachment region and a first magnet. The first attachment region forms a receiving portion at a surface of the assembly base. The first magnet in the assembly base is disposed at the receiving portion. The handheld controller is attachable to the assembly base via the first magnet in the handheld controller and the first magnet in the assembly base.
Patent EP-3245962-A2 (EP)
Inventor: KRIEGER JOSHUA F
IPC: A61B17/12
Filed: 2017-05-16
Abstract: A method of treating a vessel, such as sclerotherapy, includes moving a short balloon catheter to a position at which a compliant extra-luminal balloon is outside of the vessel at an occlusion site, and between the vessel and a non-compliant bearing surface. The vessel is occluded at the occlusion site by inflating the compliant extra-luminal balloon of the balloon catheter, and bearing an outer surface of the balloon against the vessel and the non-compliant bearing surface. The vessel is medically treated upstream from the occlusion site. The short balloon catheter includes a wire guide lumen and is covered prior to inflation by a sheath.
Patent EP-3315673-A2 (EP)
Inventor: SCHELL JOACHIM
IPC: E03D1/36
Filed: 2017-10-04
Abstract: Die Erfindung betrifft eine Vorrichtung zur Durchführung der Spülung von Leitungen einer Wasser-Gebäudeinstallation, umfassend eine Schwimmersteuerung (9), welche ein Füllventil (2) im Zulauf betätigt, das mittels einer Anschlussleitung (44, 144) und eines Eckventils (4, 104, 204) an die Wasser-Gebäudeinstallation angeschlossen ist, und die mit einem Ablaufventil (3) versehen ist, das über eine mechanische oder elektronische Auslöseeinheit betätigbar ist, wobei das Ablaufventil (3) eine Überlaufbohrung (31) aufweist, die in einen Ablaufkanal (11) mündet. Im Zulauf ist mindestens ein Abzweig (42, 142, 242, 147) vorgesehen ist, der ein Ventil (5, 105, 205) und / oder einen Sensor (107, 207) mit der Wasser-Gebäudeinstallation verbindet. Das Füllventil (2) kann ein Magnetventil (205) sein und die Schwimmersteuerung (9) kann als Sensor zur Feststellung des Füllstands ausgeführt sein.
Patent EP-3316038-A2 (EP)
Inventor: HE SHIFENG
IPC: G03F7/20
Filed: 2017-10-27
Abstract: An apparatus for detecting a mark on a substrate is provided. The mark has a first stripe group and a second stripe group disposed in parallel to each other. The apparatus includes a detection module operative to move over a surface of the substrate. The detection module includes a detection unit for obtaining data from the mark and operative to perform repeated acquisition operations on the first stripe group and the second stripe group of the mark. Each of the acquisition operations acquires data associated with the first stripe group or the second stripe group of the mark. The detection module also includes a positioning unit for aligning the detection unit with the mark.
Patent EP-3442415-A2 (EP)
Title: Procédés et dispositifs de mesure des niveaux d'analytes dans des liquides organiques
Inventor: CLARKE SUSAN ELIZABETH
IPC: B01L3/00
Filed: 2017-04-13
Abstract: Un procédé de test d'un analyte chez un individu consiste à fournir des informations de couleur obtenues à partir d'une image numérique d'un réactif coloré sur une bandelette de test d'analyte, le réactif coloré ayant été généré en fonction d'un analyte dans un échantillon d'essai, à convertir les informations de couleur de l'image en un niveau d'analyte, à enregistrer le niveau d'analyte en association avec des informations spécifiques à l'utilisateur (par exemple un code QR), à répéter les étapes précédentes pour obtenir au moins deux enregistrements de niveaux d'analyte pour le même utilisateur à des moments différents et à utiliser les enregistrements pour surveiller la santé personnelle ou pour prédire le développement probable d'une maladie ou d'un état ou pour diagnostiquer une maladie ou un état ou pour surveiller un régime de traitement associé à une variation des niveaux d'analyte dans la salive.
Patent EP-3439658-A2 (EP)
Title: Antagonistes de c5ar solubles
Inventor: FAN PINGCHEN
IPC: A61K31/451
Filed: 2017-04-03
Abstract: L'invention concerne des composés pour moduler le récepteur C5a. Lesdits composés présentent la formule suivante (I) comprenant des stéréoisomères et des sels pharmaceutiquement acceptables, R1, R2 et R3 étant tels que définis dans la description. L'invention concerne également, d'une part des procédés associés à l'élaboration et à l'utilisation de tels composés, et d'autre part des compositions pharmaceutiques comprenant de tels composés.
Patent EP-3518908-A2 (EP)
Inventor: MARTIN PARTHENA
IPC: A61K31/5375
Filed: 2017-09-29
Abstract: L'invention concerne des analogues fonctionnels de fenfluramine. Les analogues fonctionnels de fenfluramine selon l'invention trouvent des applications dans le traitement de différentes maladies. L'invention concerne par exemple des méthodes de traitement de l'épilepsie par administration d'un analogue de fenfluramine à un sujet ayant besoin d'un tel traitement. L'invention concerne également des méthodes de traitement d'une maladie neurodégénérative chez un sujet ayant besoin d'un tel traitement. L'invention concerne aussi des compositions pharmaceutiques destinées à être utilisées dans le cadre de la mise en œuvre des méthodes selon l'invention.
Patent EP-3438019-A2 (EP)
Inventor: BISCHOFF MARTIN
IPC: B65D75/66
Filed: 2018-07-20
Abstract: Bei einer Packung (10), vorzugsweise Zigarettenpackung, ist eine Banderole (11), vorzugsweise eine Steuer-Banderole, im Bereich einer Rückwand (18) der Packung (10), benachbart zu einer Bodenwand, angebracht. Die vorzugsweise rechteckige Banderole (11) ist mit mehreren in Reihen angeordneten Leimpunkten an der Packung (10) befestigt, insbesondere durch randseitige Reihen aus Heißleimpunkten (19, 20) und mindestens eine mittlere Reihe von Kaltleimpunkten (21). Weiterhin ist die Banderole (11) mit einem Stanzabschnitt (24) aus mehreren Stanzlinien (23) versehen, in deren Bereich sich mindestens einzelne Leimpunkte (20, 21) befinden.
Patent EP-3477368-A2 (EP)
Inventor: PARK SE-HYUN
IPC: G02F1/13357
Filed: 2018-10-05
Abstract: A liquid crystal display device includes: a display panel including a red pixel, a green pixel, and a blue pixel; and a backlight unit which emits light to the display panel, wherein the backlight unit comprises: a light source which outputs a first color light; a color conversion layer which is disposed on the light source and converts the first color light into a second color light; an optical sheet which diffuses or condenses the second color light; and an air gap formed between the color conversion layer and the optical sheet.
Patent EP-3667593-A2 (EP)
Inventor: YOO CHANG HUN
IPC: G06Q20/38
Filed: 2018-07-11
Abstract: The present invention relates to a virtual token-based settlement providing system, a virtual token generation apparatus, a virtual token verification server, a virtual token-based settlement providing method, and a virtual token-based settlement providing program. The present invention comprises: a step for receiving a virtual token provided by a virtual token generation means, by a virtual token verification means (S200); a step for extracting multiple detailed codes included in the virtual token by the virtual token verification means (S400); a step for searching for a storage location of an actual card number on the basis of the multiple detailed codes by the virtual token verification means (S1000); and a step for transmitting the searched actual card number to a payment settlement service server or a financial company server (S 1200).
Patent EP-3648782-A2 (EP)
Inventor: SIVAS HULYA
IPC: A61P35/00
Filed: 2018-07-05
Abstract: The invention relates to use ferruginin A (FGA) compound that presents an effective cytotoxic activity in cancer chemotherapy as an anticancer agent and MAPK pathway inhibitor. The objective of the invention is to use Ferruginin A (FGA) compound that can be isolated from the bark of Harungana madagascariensis, as an anticancer agent and as MAPK pathway inhibitor at MCF-7 cells. The fact that Ferruginin A presents low effect on human normal skin fibroblasts, thus presents selective toxicity towards the cancer cells selective toxicity is exploited under the scope of the invention.
Patent EP-3777677-A2 (EP)
Title: Soft exosuit for assistance with human motion
Inventor: WALSH CONOR
IPC: A61H3/00
Filed: 2014-05-30
Abstract: In one aspect, a motion control system includes an actuator having an actuation member, the actuation member having a proximal end attached to the actuator on a first side of a joint and a distal end attached to an anchor element attachment point on a second side of the joint. A first sensor is configured to output signals defining a gait cycle and a second sensor is configured to output signals representing a tensile force in the at least one actuation member. A controller receives the output signals from the first and second sensors and, responsive thereto, automatically actuates the actuator, during a first portion of the gait cycle, to apply a force greater than a predetermined threshold tensile force to the anchor element attachment point via the actuation member to generate a beneficial moment about the joint and to automatically actuate the actuator, during at least a second portion of the gait cycle, to reduce a tensile force at the anchor element attachment point to a level at or below the predetermined threshold tensile force to avoid generating a detrimental moment about the joint.
Patent EP-3801635-A2 (EP)
Inventor: BOITANO ANTHONY
IPC: A61K39/395
Filed: 2019-06-07
Abstract: The invention relates to dosing regimens for antibody drug conjugates, as well as methods of administering said dosing regimens to patients suffering from or at risk of various diseases and conditions such as autoimmune diseases, cancers, and Graft versus Host Disease (GvHD), among others, by administration of an antibody drug conjugate (ADC), capable of binding an antigen expressed by a hematopoietic cell, such as a hematopoietic stem cell, an immune cell or a cancer cell.
Patent EP-3669882-A2 (EP)
Inventor: ELIAZ ISAAC
IPC: A61P37/04
Filed: 2012-02-28
Abstract: Modified Citrus Pectin is comprised of short, slightly -branched carbohydrate chains derived from citrus fruit peels alter by decreasing the molecular weight and degree of esterification. MCP is demonstrated herein to induce the activation of T-cytotoxic/suppressor cells, B-cells and NK-cells. Administration of MCP to mammals offers a method to enhance immune system responses of this kind in mammals in need of the same using safe and familiar materials.
Patent EP-3680421-A2 (EP)
Inventor: CAPPELLE MARK
IPC: E04F15/04
Filed: 2007-03-22
Abstract: Floor covering, consisting of floor elements, which, at least at two opposite sides, comprise a male and a female coupling part (9-10), which allow that two of such floor elements (1) can be interconnected at the respective sides (7-8) by means of a turning movement and/or a horizontal shifting movement, characterized in that at least one of said coupling parts, either the male coupling part (9) or the female coupling part (10), is made as least partially in a filled synthetic material composite.
Patent EP-3718557-A2 (EP)
Inventor: RIFF DENNIS
IPC: A61K38/04
Filed: 2014-02-25
Abstract: This invention provides a method of colonic cleansing.
Patent EP-3735109-A2 (EP)
Inventor: CHEMEL BRIAN J
IPC: H05B44/00
Filed: 2012-03-20
Abstract: A presence and an absence of a person or object of interest (an "occupant") is detected, and an occupancy sensor signal is generated indicating an active state in which the presence of the occupant is detected, and an inactive state in which the absence of the occupant is detected. An ambient light sensor detects the ambient light level and generates an ambient light sensor signal indicating the ambient light level. Dimmable illumination is generated at a first level, based on the ambient light level, corresponding to the active state and a second level corresponding to the inactive state. A transition delay time between an onset of the inactive state and a transition between the first dimming level and the second dimming level may be controlled. The first dimming level, the second dimming level, and/or the transition delay time may be variably set or controlled locally or via a remote device.
Patent EP-4110174-A2 (EP)
Inventor: SAKAMOTO TAKUYA
IPC: A61B5/08
Filed: 2021-03-01
Abstract: A vital information acquisition apparatus includes an ultra-wideband millimeter-wave radar system which includes at least one transmitting antenna and at least one receiving antenna and is configured to transmit ultra-wideband millimeter-waves to a subject and receive ultra- wideband millimeter-waves reflected by the subject, and a controller includes circuitry that converts a plurality of received ultra- wideband millimeter-waves to radar signals reflected by the subject, stores the radar signals, calculates the differential signals among the radar signals at each position, calculates the intensity of the differential signals at each position, and estimates respiratory intervals, heartbeat intervals and position of the subject.
Patent EP-4243703-A2 (EP)
Inventor: TENNENBAUM GAD
IPC: A61B17/04
Filed: 2021-11-11
Abstract: An implant (550) comprises a patch (610), a patch anchor (640), a downstream assembly (700) comprising a winch (720) coupled to a winch anchor (710), and a tether (560) tethering the winch to the patch. A delivery tool (800) comprises a shaft (810), a clasp (830), a driver (850), and one or more driveshafts (880, 882) extending through the shaft. The clasp is configured to grasp a leaflet of a valve of a heart of a subject. The driver is configured to anchor the patch to the leaflet by driving the patch anchor through the leaflet while the portion of the leaflet remains grasped by the clasp. The driveshafts are operatively coupled to the downstream assembly so as to anchor the winch anchor to ventricular tissue of the heart by applying an anchoring force to the winch anchor, and to actuate the winch independently of applying the anchoring force.
Patent EP-4088921-A2 (EP)
Inventor: MATSUOKA AKIFUMI
IPC: B29C70/20
Filed: 2022-04-27
Abstract: A method of manufacturing a rubber composite includes: 
a reel installation step of installing a reel group as multiple reels each having two or three steel cords wound, in a steel cord supplying device; 
a pulling-out step of pulling out the steel cords wound on each reel; 
an arranging step of, for a steel cord group as multiple steel cords pulled out from the reel group, arranging the steel cords constituting the steel cord group in a row; and 
a rubber composite manufacturing step of embedding the steel cord group into rubber to manufacture the rubber composite, 
wherein a steel cord is a single-wire steel cord, and 
wherein when supplying to the arranging step, tension is applied to each of the steel cords that constitute the steel cord group, where the tension is greater than or equal to 6.0% and less than or equal to 9.0% of a breaking load per steel cord.
Patent EP-4044173-A2 (EP)
Title: Method and apparatus for text to speech, electronic device and storage medium
Inventor: ZHOU YI
IPC: G10L13/04
Filed: 2022-06-02
Abstract: A method for TTS includes: acquiring, TTS tasks to be processed and software identifiers corresponding to the TTS tasks, on a terminal device; determining a current scene of the terminal device and priorities corresponding to the software identifiers in the current scene; acquiring a sorting result by sorting the TTS tasks based on the priorities corresponding to the software identifiers; and executing the TTS tasks based on the sorting result.
Patent EP-4160625-A2 (EP)
Title: Cable for electric power transmission
Inventor: YIN WEIJUN
IPC: H01B7/42
Filed: 2022-08-09
Abstract: A cable that includes a conductor defining a hollow interior, a casing surrounding the conductor, an electrical insulator positioned between the conductor and the casing, and a fluid positioned within the hollow interior of the conductor.
Patent EP-4280886-A2 (EP)
Inventor: TORO-SIERRA JOSÉ
IPC: A23C19/045
Filed: 2022-01-17
Abstract: A method for the manufacture of a cream cheese There is provided a method for the manufacture of a cream cheese, the method comprising: (i) providing cheese curds, (ii) providing a whey protein solution comprising ideal whey, (iii) subjecting the whey protein solution to a cavitation treatment sufficient to heat the whey protein solution to a temperature of at least 70°C to provide a heat-treated whey protein solution, (iv) mixing the cheese curds and the heat-treated whey protein solution to form a mixture, and (v) subjecting the mixture to a texture-building heat-treatment to form the cream cheese.
Patent EP-4288073-A2 (EP)
Inventor: ATANACKOVIC DJORDJE
IPC: A61K35/17
Filed: 2022-02-04
Abstract: Disclosed are CAR polypeptides comprising a target specific receptor and a death domain. Disclosed are CAR polypeptides comprising a LINGO 1 antigen binding domain, a transmembrane domain, and an intracellular signaling domain. Disclosed are CAR cells comprising one or more of the disclosed CAR polypeptides. Disclosed are cells comprising an altered α4β1 integrin. Disclosed are methods of treating comprising administering one or more of the disclosed cells to a subject in need thereof.
Patent EP-4258361-A2 (EP)
Inventor: MOENS PETER
IPC: H01L29/40
Filed: 2023-03-10
Abstract: An accumulation MOSFET includes a plurality of device cells. Each device cell includes a mesa adjoining a vertical trench is disposed in a doped semiconductor substrate. The mesa has a top mesa portion disposed on a bottom mesa portion. The top mesa portion has a width that is narrower than a width of the bottom mesa portion. The vertical trench adjoining the mesa has a top trench portion and a bottom trench portion. The top trench portion has a width that is wider than a width of the bottom trench portion. A dielectric is disposed on a sidewall of the vertical trench. A gate electrode disposed in the top trench portion forms an accumulation channel region in the top mesa portion and a shield electrode disposed in the bottom trench portion forms a depletion drift region in the bottom mesa portion.
Patent EP-4233896-A2 (EP)
Inventor: HEGMANS JOSEPHUS PETRUS JOHANNES JACOBUS
IPC: A61K39/00
Filed: 2013-12-20
Abstract: The present invention relates to a method for the preparation of an immunogenic lysate from mesothelioma tumor cells, to such a lysate and to dendritic cells loaded with the lysate, the present invention further relates a pharmaceutical composition comprising such lysate or dendritic cells, to the use of the lysate, and to said loaded dendritic cells or said pharmaceutical composition for use in the prevention or treatment of mesothelioma.
Patent EP-4221017-A2 (EP)
Inventor: WONG SHIN HORNG
IPC: H04L1/08
Filed: 2020-01-10
Abstract: A communications device configured to transmit data to an infrastructure equipment of a wireless communications network is provided. The communications device comprises transceiver circuitry configured to transmit signals and receive signals via a wireless access interface provided by the wireless communications network, and controller circuitry configured to control the transceiver circuitry, to generate a plurality of encoded bits by encoding uplink data, to transmit, to the infrastructure equipment, the plurality of encoded bits in a plurality of Orthogonal Frequency-Division Multiplexed, OFDM, symbols in radio resources forming a physical uplink shared channel, PUSCH, of the wireless access interface, the PUSCH being divided between a first segment located in a first time divided slot of the wireless access interface and a second segment located in a second time divided slot of the wireless access interface. In at least some embodiments, at least one of the first segment and the second segment comprises all of the plurality of encoded bits such that the at least one of the first segment and the second segment can be independently decoded by the infrastructure equipment to recover the uplink data. In at least some embodiments, each of the first segment and the second segment comprises at least one demodulation reference signal, DMRS, associated with the each of the first segment and the second segment. In at least some embodiments, the first segment comprises a first code block group and the second segment comprises a second code block group, each of the first code block group and the second code block group comprising one or more code blocks each comprising a cyclic redundancy check, CRC. In at least some embodiments, the portion of the PUSCH in the first segment and the portion of the PUSCH in the second segment are formed by the communications device using a same rate matching.
Patent EP-4233800-A2 (EP)
Inventor: MIKA YUVAL
IPC: A61F2/24
Filed: 2017-04-21
Abstract: The present disclosure relates to methods and systems for controlling blood pressure and describes in an example a system for reducing blood pressure in a patient, the system comprising: a stimulation circuit configured to deliver a stimulation pulse to at least one cardiac chamber of a heart of the patient; and at least one controller configured to execute the delivery of one or more stimulation patterns of stimulation pulses to the at least one cardiac chamber over a time interval, wherein a first stimulation pattern of the one or more stimulation patterns reduces the blood pressure of the patient by a first reduction amount, wherein a second stimulation pattern of the one or more stimulation patterns reduces the blood pressure of the patient by a second reduction amount, wherein the first reduction amount is greater than the second reduction amount, wherein the second reduction amount is greater than zero, wherein the time interval is a 24-hour period, wherein the first stimulation pattern and the second stimulation pattern are delivered based on the need of the patient during the 24-hour period, and wherein the first stimulation pattern is delivered during a period of a first level of activity by the patient and the second stimulation pattern is delivered during a period of a second level of activity by the patient, and wherein the first level is lower than the second level.